全球个人化医疗市场规模、份额、趋势和成长分析报告（2026-2034年）

预计个人化医疗市场将从 2025 年的 5,082.7 亿美元成长到 2034 年的 1,8,048.8 亿美元，2026 年至 2034 年的复合年增长率为 15.12%。

基因组学和生物技术的进步正在推动个人化医疗解决方案的发展，个人化医疗市场预计将迎来显着成长。个人化医疗是指根据个体的特征（例如遗传特征、生活方式和环境因素）来客製化治疗方案。慢性病发病率的上升以及对标靶治疗需求的成长正在推动对个人化医疗的投资，并进一步扩大市场规模。此外，对改善患者预后和降低医疗成本的关注也促进了个人化治疗方法的应用。

技术创新在塑造个人化医疗市场的未来方面发挥着至关重要的作用。基因组学、生物资讯学和数据分析领域的创新正在增强识别特定生物标记和开发标靶治疗的能力。此外，人工智慧和机器学习的整合使医疗服务提供者能够分析大量数据，并就治疗方案做出明智的决策。随着行业的不断发展，预计个人化医疗市场将在各种医疗环境中更广泛地采用技术主导的解决方案。

此外，对病患参与和教育的日益重视也影响着个人化医疗市场的发展轨迹。随着患者对自身健康状况和治疗方案的了解不断加深，他们对能够满足个别需求的个人化解决方案的需求也日益增长。这一趋势正在推动医疗服务提供者、製药公司和科技公司之间的合作，并加速开发能够赋能患者积极参与自身医疗决策的教育资源和支持系统。随着市场的不断发展，科技的应用、病人参与以及个人化医疗的整合将是成功的关键。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球个人化医疗市场：依产品类型划分

• 市场分析、洞察与预测
• 诊断
• 治疗
• 个人化医疗
• 其他的

第五章：全球个人化医疗市场：依应用领域划分

• 市场分析、洞察与预测
• 肿瘤学
• 心臟病学
• 神经病学
• 感染疾病
• 其他的

第六章：全球个人化医疗市场：依技术划分

• 市场分析、洞察与预测
• 基因组学
• 药物基因体学
• 伴随诊断
• 其他的

第七章 全球个人化医疗市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 诊断中心
• 研究所
• 其他的

第八章：全球个人化医疗市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Roche
  • Thermo Fisher Scientific
  • Illumina
  • GE Healthcare
  • Abbott Laboratories
  • Danaher Corporation
  • Qiagen
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Hologic
  • Exact Sciences
  • PerkinElmer
  • Myriad Genetics
  • Foundation Medicine
  • Invitae Corporation

The Personalized Medicine Market size is expected to reach USD 1804.88 Billion in 2034 from USD 508.27 Billion (2025) growing at a CAGR of 15.12% during 2026-2034.

The Personalized Medicine Market is poised for significant growth as advancements in genomics and biotechnology enable tailored healthcare solutions. Personalized medicine involves customizing medical treatment based on individual characteristics, such as genetic makeup, lifestyle, and environmental factors. The increasing prevalence of chronic diseases and the growing demand for targeted therapies are driving investments in personalized medicine, further propelling market expansion. Additionally, the emphasis on improving patient outcomes and reducing healthcare costs is contributing to the adoption of personalized approaches in treatment.

Technological advancements are playing a crucial role in shaping the future of the personalized medicine market. Innovations in genomic sequencing, bioinformatics, and data analytics are enhancing the ability to identify specific biomarkers and develop targeted therapies. Furthermore, the integration of artificial intelligence and machine learning is enabling healthcare providers to analyze vast amounts of data and make informed decisions regarding treatment options. As the industry continues to evolve, the personalized medicine market is likely to see increased adoption of technology-driven solutions across various healthcare settings.

Moreover, the growing emphasis on patient engagement and education is influencing the personalized medicine market's growth trajectory. As patients become more informed about their health and treatment options, there is a rising demand for personalized solutions that cater to their specific needs. This trend is driving collaboration between healthcare providers, pharmaceutical companies, and technology firms to develop educational resources and support systems that empower patients to take an active role in their healthcare decisions. As the market continues to evolve, the integration of technology, patient engagement, and personalized care will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Diagnostics
• Therapeutics
• Personalized Medical Care
• Others

By Application

• Oncology
• Cardiology
• Neurology
• Infectious Diseases
• Others

By Technology

• Genomics
• Pharmacogenomics
• Companion Diagnostics
• Others

By End-User

• Hospitals
• Diagnostic Centers
• Research Laboratories
• Others

COMPANIES PROFILED

• Roche, Thermo Fisher Scientific, Illumina, GE Healthcare, Abbott Laboratories, Danaher Corporation, Qiagen, Agilent Technologies, BioRad Laboratories, Hologic, Exact Sciences, PerkinElmer, Myriad Genetics, Foundation Medicine, Invitae Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PERSONALIZED MEDICINE MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Personalized Medical Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PERSONALIZED MEDICINE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PERSONALIZED MEDICINE MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pharmacogenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Companion Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PERSONALIZED MEDICINE MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PERSONALIZED MEDICINE MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Application
  • 8.2.3 By Technology
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Application
  • 8.3.3 By Technology
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Application
  • 8.4.3 By Technology
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Application
  • 8.5.3 By Technology
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Application
  • 8.6.3 By Technology
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PERSONALIZED MEDICINE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Roche
  • 10.2.2 Thermo Fisher Scientific
  • 10.2.3 Illumina
  • 10.2.4 GE Healthcare
  • 10.2.5 Abbott Laboratories
  • 10.2.6 Danaher Corporation
  • 10.2.7 Qiagen
  • 10.2.8 Agilent Technologies
  • 10.2.9 Bio-Rad Laboratories
  • 10.2.10 Hologic
  • 10.2.11 Exact Sciences
  • 10.2.12 PerkinElmer
  • 10.2.13 Myriad Genetics
  • 10.2.14 Foundation Medicine
  • 10.2.15 Invitae Corporation